Abstract
Progressive left ventricular remodeling is characterized by dilation of the left ventricle with a change in the heart from an elliptical shape to a more spherical shape. This change is part of the unfavorable natural history in patients with heart failure. The CorCap Cardiac Support Device (Acorn Cardiovascular, St. Paul, MN) is a mesh device that is implanted around the heart to reduce wall stress and the first therapy specifically designed to address left ventricular remodeling. The CorCap was studied in a large, prospective, randomized, multicentered trial. This study demonstrated safety and effectiveness of the CorCap in patients with advanced heart failure and remodeled ventricles. Moreover, it provided interesting insights into mitral valve surgery in patients with heart failure. These insights and a review of the ACORN (Assessment of a Cardiac Support Device [CSD] in Patients With Heart Failure) trial are discussed in this article.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Baig MK, Mahon N, McKenna WJ, et al.: The pathophysiology of advanced heart failure. Heart Lung 1999, 28:87–101.
Chien KR: Stress pathways and heart failure. Cell 1999, 98:555–558.
Oz MC, Konertz WF, Kleber FX, et al.: Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 2003, 126:983–991.
Goldstein S, Ali AS, Sabbah H: Ventricular remodeling. Cardiol Clin 1998, 16:623–632.
Florea VG, Mareyev VY, Samko AN, et al.: Left ventricular remodeling: common process in patients with different primary myocardial disorders. Int J Cardiol 1999, 68:281–287.
Vasan RS, Larson MG, Benjamin EJ, et al.: Left ventricular dilation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350–1355.
Kass DA, Baughman KL, Pak PH, et al.: Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 1995, 91:2314–2318.
Batista R: Partial left ventriculectomy—the Batista procedure. Eur J Cardiothorac Surg 1999, 15(Suppl I):S12–S19.
Dor V, Saab M, Coste P, et al.: Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 1989, 37:11–19.
Sarling RC: Cardiac surgery for heart failure. Semin Thorac Cardiovasc Surg 2002, 14:122–124.
Voss B, Lange R: Dynamic cardiomyoplasty: evaluation of an alternative procedure in the treatment of terminal heart failure. Z Kardiol 2001, 90(Suppl 1):22–27.
Gummert JF, Rahmel A, Bossert T, et al.: Socks for the dilated heart. Does passive cardiomyoplasty have a role in long-term care for heart failure patients? Z Kardiol 2004, 93:849–854.
Patel HJ, Polidori DJ, Pilla JJ, et al.: Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: effects of a conditioned muscle wrap. Circulation 1997, 96:3665–3671.
Capouya ER, Gerber RS, Drinkwater DC Jr, et al.: Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg 1993, 56:867–870.
Sabbah HN, Chaudhry PA, Paone G, et al.: Passive ventricular constraint with the Acorn prosthetic jacket prevents progressive left ventricular dilation and improves ejection fraction in dogs with moderate heart failure. J Am Coll Cardiol 1999, 33:207A.
Sabbah HN, Maltsev VA, Chaudhry PA, et al.: Contractile function of cardiomyocytes isolated from dogs with heart failure is enhanced after chronic therapy with passive ventricular constraint using the acorn cardiac support device. Circulation 1999, 100:2314.
Power JM, Raman J, Byrne MJ, et al.: Passive ventricular constraint is a trigger for a significant degree of reverse remodeling in an experimental model of degenerative heart failure and dilated cardiomyopathy. Circulation 2000, 102:2442.
Saavedra WF, Tunin RS, Paolocci N, et al.: Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol 2002, 39:2069–2076.
Pilla JJ, Blom AS, Brockman DJ: Passive ventricular constraint improves left ventricular function and mechanics in a model of heart failure secondary to acute myocardial infarction. Circulation 2002, 106(Suppl I):I207–I211.
Chaudhry PA, Mishima T, Sharov VG, et al.: Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000, 70:1275–1280.
Sabbah HN, Sharov VG, Gupta RC, et al.: Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res 2003, 93:1095–1101.
Mann DL, Acker MA, Jessup M, et al.: Rationale, design and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York Heart Association Class III–IV heart failure. J Card Fail 2004, 10:185–192.
Sabbah HN, Sharov VG, Chaudhry PA, et al.: Chronic therapy with the Acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings. J Heart Lung Transplant 2001, 20:189.
Ranous NH, Paone G, Morita H, et al.: Reverse left ventricular remodeling with the Acorn cardiac support device in dogs with advanced heart failure: randomized, placebo controlled study. Circulation 2002, 106(Suppl II):II–550.
Rastogi S, Gupta RC, Mishra S, et al.: Long-term therapy with the Acorn cardiac support device normalizes gene expression as alpha-myosin heavy chain in dogs with chronic heart failure. Circulation 2002, 106(Suppl II):II–384.
Konertz WF, Kleber FX, Dushe S, et al.: Efficacy trends with the Acorn cardiac support device: two years follow-up. J Am Coll Cardiol 2002, 39(Suppl A):142A.
Raman JS, Power JM, Buxton BF, et al.: Ventricular containment as an adjunctive procedure in ischemic cardiomyopathy: early results. Ann Thorac Surg 2001, 70:1124–1126.
Acker MA: Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery. Semin Thorac Cardiovasc Surg 2005, 17:361–363.
•• Mann, DL, Acker, MA, Jessup M, et al.: Clinical evaluation of the CorCap cardiac support device in patients with dilated cardiomyopathy. Ann Thorac Surg 2007, 84:1226–1235. This is the original article describing the ACORN trial results.
•• Starling RC, Jessup M, Oh JK, et al.: Sustained benefits of the CorCap cardiac support device on left ventricular remodeling: three-year follow-up results from the Acorn clinical trial. Ann Thorac Surg 2007, 84:1236–1242. This paper provides the long-term results of the ACORN trial.
Otto CM: Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001, 345:740–746.
Koelling TM, Aaronson KD, Cody RJ, et al.: Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002, 144:524–529.
Trichon BH, Felker GM, Shaw LK, et al.: Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003, 91:538–543.
Robbins JD, Maniar PB, Cotts AW, et al.: Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J. Cardiol 2003, 91:360–362.
Kono T, Sabbah HN, Rosman H, et al.: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992, 20:1594–1598.
Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al.: Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000, 102:1400–1406.
Bolling SF, Pagani FD, Deeb GM, et al.: Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998, 115:381–386.
Bach DS, Bolling SF: Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 1996, 78:966–969.
Badhwar V, Bolling SF: Mitral valve surgery in the patient with LV dysfunction. Semin Thorac Cardiovasc Surg 2002, 14:133.
Romano MA, Bolling SF: Update on mitral repair in dilated cardiomyopathy. J Card Surg 2004, 19:396–400.
Acker MA, Bolling SF, Shemin R, et al.: Mitral valve surgery in heart failure: insights from the Acorn clinical trial. J Thorac Cardiovasc Surg 2006, 132:568–577.
Grossi EA, Crooke GA: Mitral valve surgery in heart failure: insights from the Acorn clinical trial. J Thorac Cardiovasc Surg 2006, 132:455–456.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ali, M.W., Bolling, S.F. Mitral Valve Repair: What the ACORN Trial Taught Us. Curr Cardiol Rep 12, 116–121 (2010). https://doi.org/10.1007/s11886-010-0088-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-010-0088-7